Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic Development Summit

<p>MALVERN, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that Arun Upadhyay, PhD, Ocugen’s Chief Scientific Officer, Head of Research, Development and Medical, will be among the featured speakers […]</p>
<p>The post <a href="https://forextv.com/top-news/ocugen-cso-to-participate-in-4th-annual-dry-amd-therapeutic-development-summit/">Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic Development Summit</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>